A brolucizumab trial shows improvements in visual acuity noninferior to that of aflibercept, with risks of intraocular inflammation for some.

Isolated paracentral acute middle maculopathy (iPAMM) is tied to short-term risk of a life-threatening cardiovascular event (CVE) in older adults, research in the American Journal of Ophthalmology ...

Among patients with retinal vein occlusion (RVO), microaneurysms are associated with greater nonperfusion areas and the presence of collateral, ghost, and tortuous vessels, accord ...

According to the Ophthalmological Society of South Africa (OSSA) approximately one-third of diabetic individuals will develop ...